Evidence supporting the use of: Vitamin E (tocotrienols)
For the body system: Prostate

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E, specifically its tocotrienol form, has been investigated for its potential role in supporting prostate health, primarily due to its antioxidant and anti-inflammatory properties. Several laboratory and animal studies suggest that tocotrienols can inhibit the growth of prostate cancer cells and modulate signaling pathways involved in inflammation and cell proliferation. For example, some in vitro studies have shown that tocotrienols can induce apoptosis (programmed cell death) in prostate cancer cell lines and reduce markers of oxidative stress, which is thought to contribute to prostate disease progression.

However, human clinical evidence is limited and inconsistent. Most clinical trials examining Vitamin E and prostate health have focused on alpha-tocopherol (another form of Vitamin E), rather than tocotrienols. Large-scale trials, such as the SELECT trial, found that alpha-tocopherol supplementation did not reduce—and may even increase—the risk of prostate cancer. There are few, if any, robust human trials specifically evaluating tocotrienols for prostate health.

In summary, while preclinical research provides a rationale for the use of tocotrienols in supporting prostate health, substantial human clinical evidence is lacking. Therefore, the use of tocotrienols for prostate support is considered to have preliminary scientific backing, but more high-quality studies are needed before firm recommendations can be made.

More about Vitamin E (tocotrienols)
More about Prostate

Products containing Vitamin E (tocotrienols)

We currently have no products on Vitabase that contain this ingredient.